Main page content

Displaying results 1 - 10 of 50
Publication ID: PEP23-03-10-015
Published:

This data visualization illustrates alcohol use among girls and young women, versus use among boys and young men. It also shares ways for parents, caregivers, or community members to respond and help girls and young women avoid alcohol use.

Publication ID: PEP23-03-10-002
Published:

This data visualization illustrates the correlation between alcohol use and other substance use to inform parents/guardians and communities.

Publication ID: PEP23-03-10-005
Published:

This data visualization illustrates heavy alcohol use and binge drinking statistics amongst college age youth to inform colleges and communities.

Publication ID: PEP23-03-10-003
Published:

This data visualization illustrates the drinking habits of adolescents to inform parents/guardians and communities.

Publication ID: PEP23-03-10-006
Published:

This fact sheet provides data about trending alcohol use among girls and young women.

Publication ID: PEP23-03-10-004
Published:

This fact sheet is written specifically for preteens and teens. It compares the myths with the facts about alcohol use among youth and the effects of alcohol use. This fact sheet can help parents and prevention professionals start conversations about underage drinking and alcohol misuse.

Publication ID: PEP22-03-10-004A
Published:

This data visualization illustrates the steady decline of alcohol use amongst adolescents, informing parents/guardians and communities that taking action against underage drinking is effective.

Publication ID: PEP21-02-01-004
Published:

This updated TIP reviews what is known about treating the medical, psychiatric, and SUD-related problems associated with the use of cocaine and methamphetamine, as well as the misuse of prescription stimulants. The TIP offers recommendations on treatment approaches and maximizing treatment engagement and retention, and strategies for initiating and maintaining abstinence.

Publication ID: PEP21-03-10-009
Published:

This user guide provides a digestible overview of the Report to Congress for prevention professionals, state and local agencies, and community-based organizations.

Publication ID: PEP21-02-01-003
Published:

The Executive Summary of this Treatment Improvement Protocol provides an overview on the use of the three Food and Drug Administration-approved medications used to treat opioid use disorder—methadone, naltrexone, and buprenorphine—and the other strategies and services needed to support recovery.

Displaying 1 - 10 out of 50